SIRT1 and tuberculosis: SIRT1 has been reported to contribute to the tuberculosis pathogenesis via attenuating intracellular replication, inducing a phagolysosome fusion and inhibiting persistent inflammatory responses caused by Mycobacterium tuberculosis, indicating the potential use of SIRT1 activators in designing effective therapies against tuberculosis [33].